In a common PAH model induced by hypoxia, treatment with Exo-ITGB1 inhibited pulmonary vascular remodeling, reduced inflammatory cytokine production, and slowed PAH progression, aligning with in vitro findings. Here, ITGB1 is linked to pulmonary arterial hypertension.